Clinical Trials Browser

Phase 4 × Unknown × Nivolumab × Clear all

NCT03313544 2023-04-21

Evolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1

Phase 4 Unknown

DermatologicThoracic

Lung Neoplasms, Melanoma

NCT04331626 2020-04-02

Low-dose Gemcitabine Combined With Nivolumab for Second-line and Above Line Treatment of NSCLC

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung